Guifang Lu

Guifang Lu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2017 in Oncology Reports
Verified
Journal Article
Open access
PDF file
YLYarui Li
Yarui Li
MRMudan Ren
Mudan Ren
YZYan Zhao
Yan Zhao
XLXinlan Lu
Xinlan Lu
MWMengyao Wang
Mengyao Wang
SHShuixiang He
Shuixiang He
MiR-26a is known to play an important oncosuppressive role in HCC. However, its regulatory role and relationship with other non-coding RNAs is less clear. In the present study, we report that the expression levels of miR-26a and long non-coding RNA (lncRNA) maternally expressed gene 3 (MEG3) were frequently downregulated in HCC tissues compared to matched non-malignant tissues. In addition, the expression levels of miR-26a and MEG3 were negatively correlated with the tumor sizes and TNM clinical stage in HCC patients. Overexpression of miR-26a significantly reduced the capacity of proliferation, invasion and migration of HCC cells. Moreover, we demonstrated that DNA methyltransferase 3b (DNMT3B) was a direct target gene of miR-26a. Overexpression of miR-26a suppressed the expression level of DNMT3B. Inhibited expression of DNMT3B showed similar tumor suppressive effects induced by miR-26a upregulation, and resulted in the upregulation of MEG3. Furthermore, we found that the expression levels of DNMT3B were upregulated in the HCC tissues compared with non-malignant tissues, and it was inversely correlated with miR-26a and MEG3 in HCC tissues. Thus, these results provided a plausible link between the observed reduction of miR-26a and MEG3 in HCCs. Together, the present study added miR-26a/DNMT3B/MEG3 axis to the complex mechanisms of HCC development.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
YZYan Zhao
Yan Zhao
MRMudan Ren
Mudan Ren
GLGuifang Lu
Guifang Lu
XLXinlan Lu
Xinlan Lu
YYYan Yin
Yan Yin
SHShuixiang He
Shuixiang He
Background. Acute variceal bleeding is a major cause of death in liver cirrhosis. This large scale retrospective cohort study aims to analyze the prognosis of patients with cirrhosis and acute variceal bleeding and to validate the current prognostic models. Methods. Patients with cirrhosis and acute variceal bleeding were enrolled from Jan 2019 to March 2020. The independent prognostic factors for in‐hospital death were identified by logistic regression analyses. Area under curves (AUCs) was compared among Child‐Pugh, cirrhosis acute gastrointestinal bleeding (CAGIB) score, and model for end‐stage liver disease (MELD) and neutrophil‐lymphocyte ratio (NLR) scores. Results. Overall, 379 patients with liver cirrhosis and acute variceal bleeding were consecutively evaluated. The majority of the patients were males (59.1%) and the mean age of all patients were 53.7 ± 1.3 years (range 14‐89). Hepatitis B virus (HBV) was the most common underlying cause of liver cirrhosis (54.1%). 72 (19%) patients had hepatocellular carcinoma. Multivariate logistic regression analyses showed that age, HCC, WBC, total serum bilirubin, serum creatinine, and ALT were independently associated with in‐hospital death. And the odds ratios (ORs) for in‐hospital death were 1.066 (95% CI 1.017‐1.118, P = 0.008), 7.19 (95% CI 2.077‐24.893, P = 0.001), 1.123 (95% CI 1.051‐1.201, P = 0.001), 1.014 (95% CI 1.005‐1.023, P = 0.003), 1.012 (95% CI 1.004‐1.021, P = 0.006), and 1.005 (95% CI 1.000‐1.009, P = 0.036), respectively. In the whole cohort with HCC patients, the AUCs of Child‐Pugh, CAGIB, MELD and NLR scores were 0.842 (95% CI 0.801‐0.878), 0.840 (95% CI 0.799‐0.876), 0.798 (95% CI 0.754‐0.838), and 0.688 (95% CI 0.639‐0.735), respectively. The differences were statistically significant between Child‐Pugh and NLR scores (P = 0.0118), and between CAGIB and NLR scores (P = 0.0354). Conclusion. Child‐Pugh and CAGIB scores showed better predictive performance for prognosis of patients with cirrhosis and acute variceal bleeding than NLR scores.

31 July 2020 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
YZYan Zhao
Yan Zhao
MRMudan Ren
Mudan Ren
XWXin Wang
Xin Wang
GLGuifang Lu
Guifang Lu
XLXinlan Lu
Xinlan Lu
SHShuixiang He
Shuixiang He
Poor adherence to treatment instructions may play an important role in the failure of Helicobacter pylori eradication. The aim of this study was to evaluate the effects of telephone-based reeducation on 14-day quadruple H. pylori eradication therapy. In total, 162 patients were randomly assigned (1 : 1) to either the intervention group (patients received telephone-based reeducation on the 4th, 7th, and 10th days of the course) or the control group (patients received instructions only at the time of getting the prescriptions). All patients received a 14-day quadruple H. pylori eradication therapy. The primary outcome was the H. pylori eradication rate. The secondary outcomes included the symptom relief rates and the incidence rates of adverse events. Seventy-five patients in the reeducation group and 74 patients in the control group completed the follow-up. The H. pylori eradication rate in the reeducation group was statistically higher than that in the control group (intention-to-treat: 72.8% vs. 50.6%, P=0.006; per-protocol: 78.7% vs. 55.4%, P=0.003). However, the symptom relief rates and the adverse event rates in these two groups were not significantly different. Overall, the results from this study suggest that telephone-based reeducation can be potentially applied to improve the H. pylori eradication rate in clinical practice, without significantly increasing the adverse effects.

14 October 2022 in Biological Procedures Online
Verified
Journal Article
Open access
PDF file
XZXu Zhang
Xu Zhang
WCWenwen Chen
Wenwen Chen
DGDan Guo
Dan Guo
YLYarui Li
Yarui Li
YZYan Zhao
Yan Zhao
SHShuixiang He
Shuixiang He
Background: Emerging evidence have revealed that circRNAs exert important biological effects in the development and progression of various diseases, including cancer. Our study aimed to elaborated the biological effects of hsa-circ_0003570 in hepatocellular carcinoma (HCC) development at the molecular level. Results: The results of functional experiments showed that knockdown of circ_0003570 induced HCC cell growth, migration and invasion, whereas overexpression of circ_0003570 presented the opposite effects. In vivo experiments, xenograft tumors grown from circ-overexpressed cells had smaller tumor volume and weight than the control group. Further investigations suggested that circ_0003570 may function as a competing endogenous RNA via competitively binding miR-182-5p and thereby regulating the repression of downstream target gene STARD13, which were demonstrated by dual luciferase reporter assay and functional rescued experiments. Conclusions: Taken together, circ_0003570 suppresses the development of HCC by modulating miR-182-5p/STARD13 axis.